55 related articles for article (PubMed ID: 2125776)
1. [Long-term treatment of cryptogenic hepatitis C using recombinant interferon alpha].
Hopf U; Möller B; König V; Küther S; Lobeck H; Huhn D
Z Gastroenterol; 1990 Sep; 28(9):453-7. PubMed ID: 2125776
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
3. Interferon therapy for acute posttransfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status.
Ohnishi K; Nomura F; Nakano M
Am J Gastroenterol; 1991 Aug; 86(8):1041-9. PubMed ID: 1650129
[TBL] [Abstract][Full Text] [Related]
4. Sustained remission and viraemia in chronic hepatitis C treated with recombinant alpha-interferon (rIFN-alpha).
Bresci G; Gambardella L; Parisi G; Banti S; Scatena F; Bertoni M; Capria A
Int J Clin Pharmacol Res; 1995; 15(5-6):175-9. PubMed ID: 8835615
[TBL] [Abstract][Full Text] [Related]
5. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
6. Recombinant interferon-alpha and ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up.
Angelico M; Gandin C; Pescarmona E; Rapicetta M; Del Vecchio C; Bini A; Spada E; Baroni CD; Capocaccia L
Am J Gastroenterol; 1995 Feb; 90(2):263-9. PubMed ID: 7847298
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic relevance of hepatitis C virus genotype for responsiveness to interferon-alpha].
Berg T; König V; Küther S; Heuft HG; Wittmann G; Lobeck H; Hopf U
Z Gastroenterol; 1995 Aug; 33(8):426-30. PubMed ID: 7483733
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic hepatitis C with interferon alpha: long-term follow-up and prognostic relevance of HCV genotypes.
Hopf U; Berg T; König V; Küther S; Heuft HG; Lobeck H
J Hepatol; 1996; 24(2 Suppl):67-73. PubMed ID: 8836892
[TBL] [Abstract][Full Text] [Related]
9. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996
[TBL] [Abstract][Full Text] [Related]
10. Detection of anti-HCV IgM antibodies in patients with chronic hepatitis C treated with interferon.
Picciotto A; Icardi G; Bardellini E; Borro P; Borzone S; Pireddu M; Sinelli N; Pezzano D; Orione L; Di Giacomo C
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):623-5. PubMed ID: 8590156
[TBL] [Abstract][Full Text] [Related]
11. Pilot study of a short course of ribavirin and alpha interferon in the treatment of chronic active hepatitis C not responding to alpha-interferon alone.
Scotto G; Fazio V; Tantimonaco G
Ital J Gastroenterol; 1996 Dec; 28(9):505-11. PubMed ID: 9131395
[TBL] [Abstract][Full Text] [Related]
12. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
[TBL] [Abstract][Full Text] [Related]
13. [Recombinant alfa interferon in the treatment of chronic B and non-A, non-B hepatitis: preliminary results].
da Silva LC; Carrilho FJ; da Fonseca LE; Farias SM; Faggion P; Granato CF; Vianna MR; Alves VA; Gayotto LC
Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(5):201-6. PubMed ID: 2517713
[TBL] [Abstract][Full Text] [Related]
14. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy.
Mazzaro C; Franzin F; Tulissi P; Pussini E; Crovatto M; Carniello GS; Efremov DG; Burrone O; Santini G; Pozzato G
Cancer; 1996 Jun; 77(12):2604-13. PubMed ID: 8640712
[TBL] [Abstract][Full Text] [Related]
15. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human alpha-interferon therapy for chronic non-A, non-B hepatitis: second report.
Kakumu S; Arao M; Yoshioka K; Hayashi H; Kusakabe A; Hirofuji H; Kawabe M
Am J Gastroenterol; 1990 Jun; 85(6):655-9. PubMed ID: 2112882
[TBL] [Abstract][Full Text] [Related]
17. Therapy for chronic viral hepatitis.
Alvarez F
Clin Invest Med; 1996 Oct; 19(5):381-8. PubMed ID: 8889278
[TBL] [Abstract][Full Text] [Related]
18. Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.
Di Bisceglie AM; Martin P; Kassianides C; Lisker-Melman M; Murray L; Waggoner J; Goodman Z; Banks SM; Hoofnagle JH
N Engl J Med; 1989 Nov; 321(22):1506-10. PubMed ID: 2509917
[TBL] [Abstract][Full Text] [Related]
19. Antibody pattern's lack of predictivity in determining the response of viral hepatitis C to interferon therapy.
Berardo C; Gerardi R; Delle Monache M; Del Vecchio S; Ricci GL
Ital J Gastroenterol; 1994; 26(8):398-400. PubMed ID: 7535599
[TBL] [Abstract][Full Text] [Related]
20. Treatment of posttransfusion non-A, non-B acute and chronic hepatitis with human fibroblast beta-interferon: a preliminary report.
Ohnishi K; Nomura F; Iida S
Am J Gastroenterol; 1989 Jun; 84(6):596-600. PubMed ID: 2499184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]